Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer

Lung Cancer

Volumn 64, Issue 2, 2009, Pages 238-243

  Wang, Si yu ^a   Ye, Xiong ^a   Ou, Wei ^a   Lin, Yong bin ^a   Zhang, Bin bin ^a   Yang, Hua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Brain metastases; Non small cell lung cancer; Prophylactic cranial irradiation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRAIN METASTASIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM METASTASIS; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM STAGING; PNEUMONECTOMY; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 63049088734     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.08.012     Document Type: Article

References (24)

1. Ceresoli G.L., Gregorc V., Cappuzzo F., et al. ZD1839 in non-small cell lung cancer (NSCLC) patients with brain metastases (BM). Proc Am Soc Clin Oncol 22 (2003) 674 (abstr 2709)
2. Mamon H.J., Yeap B.Y., Jänne P.A., et al. High Risk of brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol 23 (2005) 1530-1537
3. Andre F., Grunenwald D., Pujol J.L., et al. Patterns of relapse of N2 non-small cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered?. Cancer 91 (2001) 2394-2400
4. Auperin A., Arriagada R., Pignon J.P., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341 (1999) 476-484
5. Cox J.D., Stanley K., Petrovich Z., et al. Cranial irradiation in cancer of the lung of all cell types. JAMA 245 (1981) 469-472
6. Russell A.H., Pajak T.E., Selim H.M., et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: Results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Oncol Biol Phys 21 (1991) 637-643
7. Umsawasdi T., Valdivieso M., Chen T.T., et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neuro-Oncol 2 (1984) 253-259
8. Stuschke M., Eberhardt W., Pöttgen C., et al. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer after multimodality treatment Long-team follow-up and investigations of late neuropsychologic effects. J Clin Oncol 17 (1999) 2700-2709
9. Albain K.S., Rusch V.W., Crowley J.J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13 (1995) 1880-1892
10. Pöttgen C., Eberhardt W., Grannass A., et al. Prophylactic cranial irradiation in operable stage IIIA non-small cell lung cancer treated with neoadjuvant chemoradiotherapy: Results from a German multicenter randomized trial. J Clin Oncol 25 (2007) 4987-4992
11. Roth J.A., Fossella F., Komaki R., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in respectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 86 (1994) 673-680
12. Rosell R., Gomez-Codina J., Camps C., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330 (1994) 153-158
13. Rosell R., Gomez-Codina J., Camps C., et al. Preresectional chemotherapy in stage IIIA non-small cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 26 (1999) 7-14
14. Depierre A., Milleron B., Moro-Sibilot D., et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small cell lung cancer. J Clin Oncol 20 (2002) 247-253
15. Wang S.Y., Wu Y.L., Rong T.H., et al. Surgical treatment for stage III N2 non-small cell lung cancer. Chin J Oncol 24 (2002) 605-607
16. Le Chevalier T., Pignon J.P., Bergman B., et al. PL-3 Results of the randomized international adjuvant lung cancer trial (IALT): Cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (PTS) with resected non-small cell lung cancer (NSCLC). Lung Cancer 41 (2003) S3
17. Gaspar L.E., Chansky K., Albain K.S., et al. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol 23 (2005) 2955-2961
18. Stuschke M., and Pottgen C. Prophylactic cranial irradiation as a component of intensified initial treatment of locally advanced non-small cell lung cancer. Lung Cancer 42 Suppl. 1 (2003) S53-S56
19. Cox J.D., Scott C.B., Byhardt R.W., et al. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCLC): Analysis of Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol 43 (1999) 505-509
20. Allen M., Chen, Thierry M., Jahan, David M., Jablons, et al. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced non-small cell lung cancer: clinical implications for the subsequent management of the brain. Cancer 109 (2007) 1668-1675
21. Wang Siyu, Ou Wei, Lin Yong-Bin, et al. A prospective randomized study of adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer. Chin J Cancer Res 19 (2007) 189-195
22. Douillard J.Y., Rosell R., Lena M.D., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7 (2006) 719-727
23. Bajard A., Westeel V., Dubiez A., et al. Multivariate analysis of factors predictive of brain metastases in localized non-small cell lung carcinoma. Lung Cancer 45 (2004) 317-323
24. Ceresoli G.L., Reni M., Chiesa G., et al. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment risk factors analysis. Cancer 95 (2002) 605-612